echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Sprinting for the second domestic Hansoh Pharmaceutical Co., Ltd. accepted the application for production of Vinorelbine tartrate soft capsules

    Sprinting for the second domestic Hansoh Pharmaceutical Co., Ltd. accepted the application for production of Vinorelbine tartrate soft capsules

    • Last Update: 2022-04-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A few days ago, CDE's official website showed that Jiangsu Hansoh Pharmaceutical's Vinorelbine tartrate soft capsules were accepted for production as a 4-type imitation, and it will be regarded as over-evaluation after approval


    The data show that vinorelbine tartrate soft capsules can be used for patients with stage IIIB-IV non-small cell lung cancer with extrapulmonary metastasis who cannot tolerate intravenous administration


    Sales of vinorelbine tartrate soft capsules in Chinese public medical institutions in recent years (unit: ten thousand yuan)

    Source: Minet.


    According to data from Minet.


    Approval of Vinorelbine Tartrate Soft Capsules

    Source: new version database of Minet

    Only two companies, Pierre Fabre and Jiangsu Hengrui Medicine, have production approvals for Vinorelbine tartrate soft capsules, and no companies have been approved


    Prior to this, Jiangsu Hansoh Pharmaceutical had 5 anti-tumor drugs under review under the new classification.


    Source: CDE official website, Minet database

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.